Cited by 45Gestational Diabetes Research and ManagementDiabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Diagnosis of gestational diabetes mellitus: it is time for international consensus

Open access
Sacks, David B·2014·Clinical Chemistry

Abstract

Gestational diabetes mellitus (GDM)2 has been defined as any degree of glucose intolerance with an onset or first recognition during pregnancy (1–3). Fetal complications of GDM include macrosomia (large baby, which leads to birth injuries), shoulder dystocia, and neonatal hypoglycemia, and adverse outcomes for the mother are an increased risk of cesarean delivery, preeclampsia, and hypertension during pregnancy, as well as a significantly higher risk of subsequent type 2 diabetes. Treating women with GDM reduces at least some of the adverse outcomes (4). Estimates of the prevalence of GDM range from <1% to 28%, reflecting the different diagnostic criteria and populations studied. The increasing prevalence of GDM in the US is congruent with the marked increase in obesity and type 2 diabetes. Pregnant women have been evaluated for diabetes for more than 50 years. Notwithstanding the 5 international workshops devoted to GDM that have been held between 1979 and 2005, there is lack of agreement concerning the optimal method to identify “any degree of glucose intolerance.” The criteria for both screening and diagnosing GDM vary considerably among countries and often between diabetes and obstetric organizations in a single country (5). Screening recommendations range from none (do not screen) to selective (screen only those at high risk) to universal. Approaches for screening tests include fasting glucose, random glucose, or, more commonly, a glucose challenge in which the patient ingests 50 g glucose (regardless of the time of the last meal). If the 1-h postload plasma glucose concentration exceeds the threshold, a full diagnostic oral glucose tolerance test (OGTT) is performed; however, 2 thresholds [140 mg/dL (7.8 mmol/L) or 130 mg/dL (7.2 mmol/L)] are generally used. Approximately 15% of women have concentrations that exceed the higher cutoff, which identifies approximately 80% of women with GDM, whereas the use of the lower cutoff increases the sensitivity to 90% but includes approximately 25% of pregnant women. Diagnosis is made with an OGTT, but, again, the criteria vary. The O'Sullivan and Mahan criteria (Table 1) form the basis for the majority of diagnostic approaches. Proposed in 1964, these criteria were derived from 752 unselected, asymptomatic pregnant women who underwent a 3-h OGTT (6). GDM was defined as 2 or more values >2 SDs above the mean. Although these arbitrary criteria were established to predict the subsequent (postpartum) development of diabetes (not necessarily to identify pregnancies with an unfavorable outcome), they became widely adopted to diagnose GDM. The cutoffs have been modified to compensate for changes in glucose measurement. In the O'Sullivan and Mahan study, glucose was measured in whole blood with the Somogyi–Nelson method. The National Diabetes Data Group (NDDG) (7) advised in 1979 that plasma be the preferred sample for glucose analysis. The NDDG raised the cutoffs for GDM (Table 1), because glucose concentrations in plasma are approximately 11% higher than in whole blood (owing to the higher concentration of water in plasma). Another concern is that the Somogyi–Nelson method, which quantifies glucose according to its ability to reduce copper, is not specific for glucose. Therefore, Carpenter and Coustan (8) lowered the cutoffs (Table 1) to reflect the more specific enzymatic assays that replaced the colorimetric assays clinical laboratories had previously used. To convert the O'Sullivan and Mahan values, Carpenter and Coustan used the formula: Plasma glucose concentration = (whole-blood glucose concentration − 5 mg/dL) × 1.14. In contrast to the 2-step procedures outlined above, the WHO recommends that GDM be diagnosed via a 1-step procedure that uses the same OGTT performed to diagnose diabetes in nonpregnant individuals, i.e., 75 g of glucose, with only the fasting and 2-h samples analyzed (Table 1). Thus, although the OGTT is universally used for diagnosis, there is no accord. The main issues in dispute are a glucose load of 100 g vs. 75 g, a duration of 2 h vs. 3 h, the cutoffs, and whether 1 or 2 high values are necessary. Adapted from Vandorsten et al. (11). The American College of Obstetricians and Gynecologists accepts either the NDDG or Carpenter and Coustan (C&C) criteria. O'Sullivan, O'Sullivan and Mahan; ADA, American Diabetes Association; EASD, European Association for the Study of Diabetes. The ADA criteria were changed in 2011 to the IADPSG criteria. Adapted from Vandorsten et al. (11). The American College of Obstetricians and Gynecologists accepts either the NDDG or Carpenter and Coustan (C&C) criteria. O'Sullivan, O'Sullivan and Mahan; ADA, American Diabetes Association; EASD, European Association for the Study of Diabetes. The ADA criteria were changed in 2011 to the IADPSG criteria. A notable flaw in the GDM diagnostic criteria is that they have been based on the risk of future hyperglycemia, not on clinical sequelae. To address this deficiency the Hy

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1373/clinchem.2013.206920

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Vandorsten JP, Dodson WC, Espeland MA, Grob- man WA, Guise JM, Mercer BM, et al. NIH con- sensus development conference: diagnosing ges- tational diabetes mellitus. NIH Consens State Sci Statements 2013;29:1-31.

Cited by

Sorted by citations

Authors
Sacks, D. B.
Affiliations
National Institutes of Health (US)
Corresponding author
Sacks, David B
Venue
Clinical Chemistry
Published
2014-01-01
Volume
60
Issue
1
Pages
141-143
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
OpenAlex
W2131657142
Cited by
45
References
16
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 5 · 2022: 1 · 2021: 1 · 2020: 5 · 2019: 3 · 2018: 6 · 2017: 5 · 2016: 2 · 2015: 10 · 2014: 1 · 2013: 1
FWCI
5.22
Type
journal article
Language
en
Open access
Locations
  • Clinical Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
gestational diabetes mellitus, diagnostic criteria, oral glucose tolerance test, glucose challenge test, GDM screening, diagnostic thresholds, international consensus, macrosomia, type 2 diabetes risk, screening sensitivity and specificity, gestational weight gain
MeSH terms
Female, Humans, International Cooperation, Pregnancy, Diabetes, Gestational, Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review